CELLZOME AG - Germany 

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:300-400
Networking Rank (Reputation):900-1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2012 0 2.999.498 0 1
2011 0 70.708.186 0 4

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGILENT TECHNOLOGIES OESTERREICH2
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DIAGENODE2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
EUROPEAN RESEARCH AND PROJECT OFFICE2
FEDERAL STATE INSTITUTION SAINT PETERSBURG RESEARCH INSTITUTE OF PHTHISIOPULMONOLOGY OF THE FEDERAL AGENCY FOR HIGH TECHNOLOGY MEDICAL AID2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA2
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
GENOMATIX SOFTWARE2
GENOME RESEARCH2
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL2
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION2
HALO GENOMICS AB2
INSTITUT PASTEUR KOREA2
ISTITUTO EUROPEO DI ONCOLOGIA2
LUNDS UNIVERSITET2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
NANOLOGICA AB2
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
OXFORD NANOPORE TECHNOLOGIES2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI2
SIENA BIOTECH2
SIGOLIS AB2
STICHTING KATHOLIEKE UNIVERSITEIT2
TASK FOUNDATION NPC2
THE BABRAHAM INSTITUTE2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
THE FEDERAL STATE SCIENTIFIC INSTITUTION SAINTPETERSBURG SCIENTIFIC RESEARCH PASTEUR INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY2
THE UNIVERSITY OF EDINBURGH2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITAET DES SAARLANDES2
UNIVERSITAET LEIPZIG2
UNIVERSITAET ULM2
UNIVERSITAETSKLINIKUM ESSEN2
UNIVERSITE DE GENEVE2
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI2
UNIVERSITY COLLEGE LONDON2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF COPENHAGEN2
UNIVERZA V LJUBLJANI2
VIVIA BIOTECH S L2
WEIZMANN INSTITUTE OF SCIENCE2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
INSERM TRANSFERT1
ONCODESIGN1
THE GARVAN INSTITUTE OF MEDICAL RESEARCH CHARITABLE INSTITUTION1
UNIVERSITA DEGLI STUDI DI BARI ALDO MORO1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITY OF SOUTHAMPTON1
VRIJE UNIVERSITEIT BRUSSEL1

Constancy:

Total number of partners: 119
Partner loyalty:
Frequent Partner: (> 2 projects): 5
Rare Partner: 114
Frequent / Rare Partner Ratio: 0.04

Project overview:

Start dateProjectacronymrolefundingpartners
2012-01-01Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MYRparticipant2.999.49810
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-01-01Open Collaborative Model for Tuberculosis Lead Optimisation ORCHIDparticipant5.357.42914
2011-01-01Open Collaborative Model for Tuberculosis Lead Optimisation ORCHIDparticipant5.357.42914

Alias institution names:

  • CELLZOME